Is rivaroxaban associated with shorter hospital stays and reduced costs vs. parenteral bridging to warfarin among pulmonary embolism patients?
28 August 2016 (17:24 - 17:42)
Organised by:
About the speaker
University of Connecticut, Storrs (United States of America)
4 More presentations in this session
Professor C. Becattini (Perugia, IT)
Doctor E. Klok (Leiden, NL)
Professor D. Brown (Los Angeles, US)
Access the full session
The Event
ESC Congress 2016
28 August 2016
17:24 CET
